Expression of epidermal growth-factor receptor in lymphangiomatosis: a new therapeutic target?
Mertsching
Heike
H
Tissue Engineering Network, Medical School Hannover, Germany. mertsching.heike@mh-hannover.de
Walles
Thorsten
T
Bakker
Gesa
G
Wildfang
Ingeborg
I
Macchiarini
Paolo
P
D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis*; D001707:Biopsy, Needle; D066246:ErbB Receptors / Q000032:analysis* / Q000187:drug effects; D006801:Humans; D007150:Immunohistochemistry; D008202:Lymphangioma / Q000188:drug therapy / Q000473:pathology*; D008479:Mediastinal Neoplasms / Q000188:drug therapy / Q000473:pathology*; D009378:Neoplasms, Multiple Primary / Q000473:pathology*; D012680:Sensitivity and Specificity
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D066246:ErbB Receptors